Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

Autor: van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.vandeloosdrecht@amsterdamumc.nl., Cremers EMP; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Alhan C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Duetz C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., In 't Hout FEM; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Visser-Wisselaar HA; HOVON Foundation, Rotterdam, The Netherlands., Chitu DA; HOVON Foundation, Rotterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Verbrugge A; HOVON Foundation, Rotterdam, The Netherlands., Cunha SM; HOVON Foundation, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Janssen JJWM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Klein SK; Department of Hematology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Muus P; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Haematology, St. James University Hospital, Leeds, UK., Langemeijer SMC; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., de Greef GE; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Raaijmakers MHG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Marwijk Kooy M; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands., Legdeur MC; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Wegman JJ; Department of Hematology, Deventer Ziekenhuis, Deventer, The Netherlands.; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Deenik W; Department of Internal Medicine, Tergooi Ziekenhuis, Hilversum, The Netherlands.; Department of Internal Medicine, Rijnstate, Arnhem, the Netherlands., de Weerdt O; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., van Maanen-Lamme TM; Department of Internal Medicine, Dijklander Ziekenhuis, Hoorn, The Netherlands., Jobse P; Department of Internal Medicine, Admiraal de Ruyter Ziekenhuis, Goes, The Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Ziekenhuis, Geleen, The Netherlands., Beeker A; Department of Hematology, Spaarne Gasthuis, Hoofddorp, The Netherlands., Wijermans PW; Department of Hematology, Haaglanden Ziekenhuis, Den Haag, The Netherlands., Biemond BJ; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Tanis BC; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands.; Department of General Practice Erasmus MC, Rotterdam, The Netherlands., van Esser JWJ; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands., Schaar CG; Department of Internal Medicine, Gelre Ziekenhuis, Apeldoorn, The Netherlands., Noordzij-Nooteboom HS; Department of Internal Medicine, Van Weel Bethesda Ziekenhuis, Dirksland, The Netherlands., Jacobs EMG; Department of Internal Medicine, Elkerliek Ziekenhuis, Helmond, The Netherlands., de Graaf AO; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Stevens-Kroef MJPL; Department of human genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Westers TM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jansen JH; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 840-850. Date of Electronic Publication: 2024 Jan 31.

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.

Autor: Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Elferink MAG; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508GA, Utrecht, The Netherlands., Mol L; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Hamers PAH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medical Center, Postbus 210, 1500EE, Zaandam, The Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Hospital, Postbus 1350, 5602ZA, Eindhoven, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Hospital, Dokter van Heesweg 2, 8025AB, Zwolle, The Netherlands., de Klerk GJ; Department of Medical Oncology, Spaarne Gasthuis, Spaarnepoort 1, 2134TM, Hoofddorp, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Postbus 9100, 3007AC, Rotterdam, The Netherlands., Haringhuizen AW; Department of Medical Oncology, Hospital Gelderse Vallei, Willy Brandtlaan 10, 6716RP, Ede, The Netherlands., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Postbus 7600, 7600SZ, Almelo, The Netherlands., Hunting JCB; Department of Medical Oncology, St. Antonius Hospital, Postbus 2500, 3430EM, Nieuwegein, The Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Oosterpark 9, 1091AC, Amsterdam, The Netherlands., Mathijssen-van Stein D; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Vlietlandplein, 3118JH, Schiedam, The Netherlands., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Postbus 888, 8901BR, Leeuwarden, The Netherlands., Pruijt JFM; Department of Medical Oncology, Jeroen Bosch Hospital, Postbus 90153, 5200ME, 's-Hertogenbosch, The Netherlands., Quarles van Ufford-Mannesse P; Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545AA, den Haag, The Netherlands., Radema S; Department of Medical Oncology, Radboud University Medical Center, Postbus 9101, 6500HB, Nijmegen, the Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Postbus 1074, 1940EB, Beverwijk, The Netherlands., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Postbus 90052, 5600PD, Eindhoven, The Netherlands., Tanis BC; Department of Medical Oncology, Groene Hart Hospital, Bleulandweg 10, 2803HH, Gouda, The Netherlands., Ten Bokkel Huinink D; Department of Medical Oncology, Diakonessenhuis Utrecht, Postbus 80250, 3508TG, Utrecht, The Netherlands., Tjin-A-Ton MLR; Department of Medical Oncology, Hospital Rivierenland, President Kennedylaan 1, 4002WP, Tiel, The Netherlands., Tromp-van Driel CS; Department of Medical Oncology, Gelre Hospital, Postbus 9014, 7300DS, Apeldoorn, The Netherlands., Troost MM; Department of Medical Oncology, Bravis Hospital Bergen op Zoom, Postbus 999, 4700AZ, Roosendaal, The Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Heerlen, Postbus 5500, 6130MB, Sittard-Geleen, The Netherlands., van der Pas AJM; Department of Medical Oncology, LangeLand Hospital, Postbus 3015, 2700KJ, Zoetermeer, The Netherlands., van der Velden AMT; Department of Medical Oncology, Tergooi, Van Riebeeckweg 212, 1213XZ, Hilversum, The Netherlands., van Dijk MA; Department of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535PA, Terneuzen, The Netherlands., van Dodewaard-de Jong JM; Department of Medical Oncology, Meander Medical Center, Postbus 1502, 3800BM, Amersfoort, The Netherlands., van Druten EB; Department of Medical Oncology, Reinier de Graaf Gasthuis, Postbus 5011, 2600GA, Delft, The Netherlands., van Voorthuizen T; Department of Medical Oncology, Hospital Rijnstate, Wagnerlaan 55, 6815AD, Arnhem, The Netherlands., Jan Veldhuis G; Department of Medical Oncology, Antonius Hospital Sneek, Postbus 20000, 8600BA, Sneek, The Netherlands., Verheul HMW; Department of Medical Oncology, Amsterdam University Medical Center, VU Medical Center, P.O. Box 7057, 1007MB, Amsterdam, The Netherlands., Vestjens HJHMJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., Vincent J; Department of Medical Oncology, Elkerliek Hospital, Postbus 98, 5700AB, Helmond, The Netherlands., Kranenburg OW; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands.; Utrecht Platform for Organoid Technology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Postbus 22660, Amsterdam, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands. M.Koopman-6@umcutrecht.nl.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (2), pp. 399-406. Date of Electronic Publication: 2020 Oct 13.

Homocysteine and coronary heart disease: Meta-analysis of MTHFR case-control studies, avoiding publication bias

Autor: Holm, H, Thorsteinsdottir, U, Gretarsdottir, S, Gulcher, Jr, Thorgeirsson, G, Andersen, K, Stefansson, K, Parish, S, Bennett, Da, Clarke, R, Peto, R, Sleight, P, Collins, R, Hopewell, Jc, Watkins, H, Saleheen, D, Danesh, J, Rasheed, A, Zaidi, M, Frossard, P, Shah, N, Samuel, M, Tanaka, T, Ozaki, K, Sato, H, Sakata, Y, Komuro, I, Anand, Ss, Yusuf, S, Engert, Jc, Chambers, J, Kooner, J, Armitage, J, Samani, Nj, Braund, Ps, Nelson, Cp, Hall, As, Balmforth, A, Ball, Sg, Kleber, Me, Hoffmann, Mm, März, Wa, Bugert, P, Winkelmann, B, Böhm, Bo, Ouwehand, Wh, Sivapalaratnam, S, Kastelein, Jj, Trip, Md, Bezzina, Cr, Ouwehand, W, Yamada, Y, Elbers, Cc, Onland Moret NC, Bauer, F, van der Schouw YT, Verschuren, Wm, de Boer JM, Wijmenga, C, Hofker, Mh, de Bakker PI, Peters, Bj, Maitland van der Zee AH, de Boer, A, Klungel, Oh, Grobbee, De, Stewart, Af, Roberts, R, Mcpherson, R, Chen, L, Wells, Ga, Reilly, Mm, Li, M, Qu, I, Rader, Dj, Thorand, B, Illig, T, Peters, A, Koenig, W, Assimes, Tl, Fortmann, S, Iribarren, C, Abbate, R, Marcucci, R, Anderson, Jl, Zebrack, Js, Ardissino, D, Merlini, Fm, Bonomi, Ab, Ashfield Watt PA, Clark, Ze, van Bockxmeer FM, Brownrigg, L, Kooner, Js, Ferrer Antunes, C, Palmeiro, A, Fernandez Arcas, N, Reyes Engel, A, Folsom, Ar, Fowkes, Fg, Lee, Aj, Gaziano, Jm, Gemmati, D, Scapoli, Gl, Genest, J, Rozen, R, Girelli, Domenico, Corrocher, Roberto, Rossi, Gb, Meleady, R, Graham, Im, Gulec, S, Hopkins, Pn, Inbal, A, Selighson, U, Jukema, Jw, Litynsky, P, Kluijtmans, La, Kozich, V, Janosikova, B, Ma, J, Stampfer, Mj, Malinow, Mr, Meisel, C, Stangl, K, Morita, H, Nagai, R, Nakai, K, Nordestgaard, Bg, Zacho, J, Rimm, Eb, Schwartz, Sm, Siscovick, Ds, Silberberg, Js, Szczeklik, A, Domagala, Bt, Tanis, Bc, Rosendaal, Fm, Thogersen, Am, Nilsson, Tk, Todesco, L, Tokgozoglu, Sl, Tsai, My, Hanson, Nq, Verhoeff, Bj, Yamakawa Kobayashi, K, Hamaguchi, H.

Publikováno v: PLoS Med. 9:e1001177 (2012)
Plos Medicine, 9
PLoS Medicine
PLoS Medicine, Vol 9, Iss 2, p e1001177 (2012)
PLoS medicine, 9(2). Public Library of Science
Plos Medicine, 9, 2

Robert Clarke and colleagues conduct a meta-analysis of unpublished datasets to examine the causal relationship between elevation of homocysteine levels in the blood and the risk of coronary heart disease. Their data suggest that an increase in homoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a940120265ccb1ebb385f7aacdc7ebe0
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=7318

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Autor: Schrader AMR; Department of Pathology., Jansen PM; Department of Pathology., Willemze R; Department of Dermatology, and., Vermeer MH; Department of Dermatology, and., Cleton-Jansen AM; Department of Pathology., Somers SF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Eijk R; Department of Pathology., Kraan W; Department of Pathology and., Kersten MJ; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., van den Brand M; Department of Pathology and., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., de Jong D; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Abdul Hamid M; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Tanis BC; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands; and., Nijland M; Department of Hematology and., Diepstra A; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Pals ST; Department of Pathology and., Cleven AHG; Department of Pathology., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Blood [Blood] 2018 May 03; Vol. 131 (18), pp. 2086-2089. Date of Electronic Publication: 2018 Mar 07.

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.

Autor: Goey KKH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht., van Tinteren H; Department of Biometrics, Netherlands Cancer Institute Amsterdam - Antoni van Leeuwenhoek Hospital, Amsterdam., Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht., Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht., Offerhaus GJA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht., Strengman E; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht., Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven., van der Velden A; Department of Medical Oncology, Tergooi Hospital, Hilversum., de Jongh FE; Department of Medical Oncology, Ikazia Hospital, Rotterdam., Erdkamp FLG; Department of Medical Oncology, Zuyderland MC, Heerlen-Sittard., Tanis BC; Department of Medical Oncology, Groene Hart Hospital, Gouda., Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Sep 01; Vol. 28 (9), pp. 2128-2134.